http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. Among patients hospitalized for heart failure (HF) with reduced left ventricular ejection fraction (LVEF; a measure of how well the left ventricle of the heart pumps with each contraction), initiation of the medication aliskiren in addition to standard therapy did not reduce cardiovascular death or HF rehospitalization at 6 or 12 months after discharge, according to a study published online by JAMA. http://medicalxpress.com/news/2013-03-combination-therapy-heart-failure-cv.html Cardiology Mon, 11 Mar 2013 14:10:01 EST news282221431 A novel study from Karolinska Institutet in Sweden suggests that commonly used drugs to treat heart failure and high blood pressure may have a wider range of application than earlier known, and also can be used against so called HFPEF—a type of heart failure that until now has been impossible to treat. The study, which is published in the scientific journal JAMA, shows that the mortality rate in a group of HFPEF patients who used these medications decreased. http://medicalxpress.com/news/2012-11-common-heart-failure-drugs-benefit.html Cardiology Tue, 27 Nov 2012 16:55:09 EST news273256549 Cancer is a complex disease and only thanks to advances in genomic techniques have researchers begun to understand, at a cellular and molecular level, the mechanisms which are disrupted in cancer cells. This knowledge is a key prerequisite for developing effective treatment strategies. http://medicalxpress.com/news/2012-11-genome-packaging-key-breast-cancer.html Cancer Thu, 22 Nov 2012 10:25:38 EST news272802331 (HealthDay)—In autopsy findings, patients treated with angiotensin receptor blockers (ARBs) show less Alzheimer's disease (AD)-related pathology, according to a study published online Sept. 10 in the Archives of Neurology. http://medicalxpress.com/news/2012-09-alzheimer-pathology-angiotensin-receptor-blocker.html Alzheimer's disease & dementia Wed, 12 Sep 2012 11:30:03 EST news266666081 Nearly 5 percent of pregnant women are prescribed drugs to treat high blood pressure, including some drugs that aren't considered safe for mothers or their babies, according to new research in the American Heart Association's journal Hypertension. http://medicalxpress.com/news/2012-09-pregnant-women-high-blood-pressure.html Cardiology Mon, 10 Sep 2012 16:00:09 EST news266501123 A traditional treatment for heart failure appears to be equally protective in preventing death or hospitalization among African-American patients, as compared to white patients, according to a study at Henry Ford Hospital in Detroit. http://medicalxpress.com/news/2012-05-difference-results-standard-heart-failure.html Cardiology Wed, 09 May 2012 17:00:02 EST news255784096 (HealthDay) -- For patients with acute myocardial infarction (AMI), pretreatment with angiotensin receptor blockers (ARBs) is linked with reduced incidence of the no-reflow phenomenon after percutaneous coronary intervention (PCI), according to a study published online April 10 in Cardiovascular Therapeutics. http://medicalxpress.com/news/2012-04-angiotensin-receptor-blockers-no-reflow-post-pci.html Cardiology Tue, 24 Apr 2012 04:50:01 EST news254457870 Treatment with an ACE inhibitor for lowering high blood pressure showed a significant mortality reduction in patients with a high prevalence of hypertension, according to a report published in the European Heart Journal, the flagship journal of the European Society of Cardiology. http://medicalxpress.com/news/2012-04-hypertension-treatment-raas-inhibitors.html Cardiology Wed, 18 Apr 2012 00:41:52 EST news253928500 (HealthDay) -- At least one in 10 U.S. adults is estimated to have chronic kidney disease, but whether screening and monitoring people in the earlier stages of the disease provides a benefit just isn't clear, a new review of the available clinical trials revealed. http://medicalxpress.com/news/2012-04-role-screening-early-kidney-disease.html Diseases, Conditions, Syndromes Tue, 17 Apr 2012 12:00:01 EST news253881510 Although observational studies have suggested that losartan, a drug used primarily for the treatment of hypertension, may be associated with an increased risk of death among patients with heart failure compared with other medications in the same class of drugs (angiotensin II receptor blockers [ARBs]), an analysis that included nearly 6,500 patients found that overall, use of losartan was not associated with increased all-cause death or cardiovascular death compared with use of the ARB candesartan, according to a study in the April 11 issue of JAMA. http://medicalxpress.com/news/2012-04-high-blood-pressure-medication-heart.html Cardiology Tue, 10 Apr 2012 16:00:01 EST news253274204 A type of medication known as angiotensin-receptor blockers could reduce risk of mortality in people with a heart disease called calcific aortic stenosis (AS) by 30 per cent over an eight-year period, Heart and Stroke Foundation researcher Dr. Philippe Pibarot told delegates at the Canadian Cardiovascular Congress. The condition is currently managed with open heart surgery. http://medicalxpress.com/news/2011-10-duty-blood-pressure-drugs-revolutionize.html Cardiology Tue, 25 Oct 2011 04:18:20 EST news238735085